Latest news and insights on the pharmaceutical industry | Indian Pharma Post
News
News | 30 November 2022

Briefs: Lupin and GMM Pfaudler

The joint venture will help both the parties to further develop the high-margin service business

News
News | 30 November 2022

Biocon Biologics completes acquisition of Viatris' Global Biosimilars Business

To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan

News
News | 30 November 2022

Zydus enters into BTA for purchase from Watson Pharma

The Business Undertaking of Watson is engaged in the business of developing, manufacturing, marketing and sale of API.

News
News | 30 November 2022

Gland Pharma to buy French pharma company Cenexi

Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group

News
News | 29 November 2022

Lupin's subsidiary MedQuimica acquires rights to nine brands from Bausch Health

The acquired brands are well established and recognized among doctors and other members of the medical fraternity in Brazil for their reliability, safety, and trustworthiness

News
News | 29 November 2022

Fredun Pharmaceuticals signs two large contracts

Fredun received one-year contract worth Rs. 65 crores from a Southeast Asian country for Pharma exports

News
News | 29 November 2022

CPhI and P-MEC India sees participation of over 1500 exhibitors

40,000 visitors and representatives of more than 80 countries set to visit the show

News
News | 28 November 2022

Azelis inaugurates pharmaceuticals & healthcare lab for APAC in India

The pharma laboratory is fully equipped with all the machinery needed to support formulation development, resolve technical challenges, and provide customer demonstrations

News
News | 27 November 2022

Early detection of lung cancer vital to combat rising mortality rate, says GlobalData

The only definitive way to diagnose and stage lung cancers is through biopsies

News
News | 27 November 2022

LPU organizes conference on welfare of global community

Joint Drugs Controller (India) Dr PBN Prasad shared his views about working during harsh COVID-19 pandemic days

News
News | 27 November 2022

Panchsheel Organics to set up fermentation/API unit

Total investment envisaged in this project stands at up to Rs 70 crore

News
News | 27 November 2022

Briefs: IOL Chemicals and Cipla

Government of India has granted a patent for invention entitled "An improved safe process for the preparation of Sartan drugs of Formula I".

News
News | 26 November 2022

Delivery solution provider ZIM Laboratories Limited lists on NSE

The total quantity traded at NSE stood at 34,653 shares and the total turnover stood at Rs. 117.23 lakh.

News
News | 26 November 2022

Ministry of Ayush and DST sign MoU to identify areas of research

The two have agreed to jointly undertake R&D activities on scientific validation of Ayush concepts, procedures and products

News
News | 26 November 2022

CPHI Frankfurt 2022: Global pharma confidence hits record high in CPHI Pharma Index

In fact, the overall CPHI Pharma Index – a collateralised metric of all major ranking categories – has risen by more than 8%, the largest year-on-year gain in the survey’s six year history

News
News | 26 November 2022

India’s plan for containment of AMR focuses on an integrated One Health approach: Dr. Bharti

It serves to leverage the strengths of various institutions to coordinate AMR surveillance lab networks

News
News | 25 November 2022

USFDA inspects Lupin's Mandideep Unit-1 facility

The inspection of the facility resulted in issuance of a Form-483 with eight observations each for the Drug Product facility and API facility at the site

News
News | 25 November 2022

Laurus Labs takes stake in Ethan Energy India

This will enable the company to consume 100% of the solar energy to be supplied by Ethan Energy India Private Limited from their 10 MW Solar Energy plant

News
News | 24 November 2022

USFDA issues warning letter to Glenmark's Goa manufacturing facility

The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility

News
News | 24 November 2022

Biocon enters commercialization agreement with Zentiva

Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe

Startup

Digitization